Six monoclonal antibodies directed against respiratory syncytial virus proteins were produced. Each was characterized by immunoprecipitation and indirect immunofluorescence. One was directed against the nucleocapsid protein, NP 44, two were directed against a 37,000-dalton protein, two were directed against the major envelope glycoprotein, GP 90, and one was directed against the 70,000-dalton envelope protein, VP 70. Indirect immunofluorescence stain patterns of infected HEp-2 cells defined GP 90 and VP 70 as viral proteins expressed on the cell surface, whereas NP 44 and the 37,000-dalton protein were detected as intracytoplasmic inclusions. One of the anti-GP 90 antibodies neutralized virus only in the presence of complement but did not inhibit cell-cell fusion. The anti-VP 70 antibody neutralized virus without complement and inhibited cell-cell fusion of previously infected HEp-2 cells, thus identifying VP 70 as the fusion protein.
Respiratory syncytial virus (RSV). an RNA virus, is the major cause of lower respiratory tract disease in infants and young children. Electron microscopy shows the virus to be 120 to 200 nm in diameter, with an envelope containing surface projections (2) . Attempts to identify and characterize the proteins of RSV have been hampered by several factors. Loss of infectivity during purification procedures and the fact that 80% of sucrose band-purified material is nonviral make the study of purified viral proteins difficult and may account for some of the discrepancies among different laboratories (8) . Between 7 and 10 presumed viral polypeptides ranging in molecular weight from 200,000 (200K) to 10K have been identified by polyacrylamide gel electrophoresis of radiolabeled RSV protein (6, 13, 15) . A 90K glycoprotein and a 50K glycoprotein have been identified and suggested as surface glycoproteins based upon their removal by trypsin and detergent treatment of purified RSV (12) . Recently, the 50K glycoprotein has been shown to be connected to a 20K protein by disulfide bonds, forming a 70K protein (9) . The functional designation of the 90K and 70K glycoproteins has not been made. A 44K protein is considered to be the nucleocapsid protein, and a 28K protein is considered to be the matrix protein (12) .
Although related to paramyxoviruses, RSV does not possess similar biochemical markers, ± Present address: SW Medical Associates. Las Vegas, NV 89109. such as a hemagglutinin or neuraminidase activity. Like the paramyxoviruses, however, RSV promotes cell-cell fusion, accounting for the characteristic giant cell syncytia formation that is seen when the virus is grown in permissive cell lines. The ability to form syncytia permits the spread of virus by fusion of infected cells to adjacent noninfected cells. It is presumed that a surface protein of the virion is responsible for the fusion process, as has been demonstrated with other viruses (4, 11) . In a study of Sendai virus, the availability of monospecific antiserum to the surface glycoproteins allowed identification of the fusion protein and hemagglutinin and permitted clarification of their roles in infectivity and the spread of virus (11) .
In anticipation that monospecific antisera to RSV proteins would aid in their identification and analysis, we produced monoclonal antibodies to RSV proteins. (7, 10) . Culture fluids were screened for anti-RSV antibody initially by an enzyme-linked immunosorbent assay and later by an indirect fluorescent-antibody (IFA) test on acetone-fixed RSV-infected HEp-2 cells. Uninfected HEp-2 cells were used as controls. Positive hybridomas were cloned twice by limiting dilution, expanded, and injected into pristane-primed mice for ascites production.
Characterization of monoclonal antibodies. Monoclonal immunoglobulin class and subclass were determined by Ouchterlony double gel diffusion analysis of hybridoma tissue culture fluids by using goat antisera with heavy-and light-chain specificities (Meloy and Litton Bionetics).
Virus neutralization. The ability of the monoclonal antibodies to neutralize RSV was assayed by a 90% plaque reduction neutralization test. Heat-inactivated ascitic fluid dilutions (100 ,ul) were mixed with 100 ,ul of media containing 50 to 100 PFU of virus, incubated for 1 h at 37°C, and then inoculated onto HEp-2 cells in 24-well Costar plates. After an adsorption period of 1 h, the virus-antibody mixture was removed and the cell sheet was overlaid with 0.6% LTG agarose (type VII; Sigma Chemical Co.) containing minimal essential medium and 5% fetal calf serum. Typical syncytial plaques were read at 4 to 5 days after fixation and methylene blue staining. Complement-enhanced neutralization was performed in parallel by the inclusion of a 1:24 dilution of fresh rabbit serum in the antibody mixture. Control experiments were done with heatinactivated rabbit serum.
Radiolabeling (Fig. 1) . This protein is considered to be the nucleocapsid protein (NP 44) (12) . Two monoclonal antibodies (L2 and G2) precipitated a 37K viral protein (Fig. 1) . Monoclonal antibody L4 precipitated both a 70K and a 50K protein (Fig.  1) . The relative intensities of the 70K and 50K proteins detected in [3'S]methionine-labeled viral lysates was determined by the duration of the labeling period. As the labeling period increased from 1 to 3 h, the amounts of 70K protein decreased and the amounts of 50K protein increased. This finding is consistent with that reported by Dubovi (6) . Two monoclonal antibodies (L7 and L9) immunoprecipitated a 90K glycoprotein (Fig. 2) . This glycoprotein is best labeled with [3H]glucosamine and is not labeled with r35Slmethionine (6. 13, 15 4C and D) . On days 2, 3, and 4, only single cells were infected, as determined by IFA staining, and syncytium formation did not occur. The number of infected cells did not appreciably increase over the 4-day period. Because L4 was used at a neutralizing dilution (1:50), any virus released from infected cells would be expected to be neutralized. DISCUSSION Of the 7 to 10 RSV-specified polypeptides previously demonstrated, only the 44K nucleocapsid protein has been given a definite structural designation (12, 15 44 antigen brane. As expected, monoclonal antibodies to J on the surfaces of syncytia when VP 37 or to NP 44 did not neutralize virus or ffect was extensive. IFA staining exert any effect on the growth pattern of RSV in P 37 antibodies (L2 and G2) also tissue cultures. *acytoplasmic inclusions (data not Based on the molecular weight and surface h anti-GP 90 and anti-VP 70 antibod-location of GP 90 of RSV, Fernie and Gerin (9) a characteristic fluorescent pattern have suggested that it may be analogous to the pheries of both acetone-fixed and hemagglutinin of the paramyxoviruses which -fixed infected cells (Fig. 3B and C) . functions as the viral glycoprotein responsible extensions protruding from the sur-for adsorption of virus to cells (14) . Although GP -cted cells were often evident with 90 of RSV does not possess hemagglutinating or untibodies, whereas anti-VP 70 anti-neuraminadase activity, it is reasonable to sus-:ed a speckled pattern.
pect that it also might function in cell attachof the spread of infection by mono-ment. The inability to neutralize RSV with our odies. Antibodies were tested for two anti-GP 90 monoclonal antibodies does not to inhibit fusion by observing the negate this possibility. These monoclonal antit of syncytia in RSV-infected HEp-2 bodies may be directed toward an epitope on GP ted in the presence of monoclonal 90 distinct from the one responsible for virusInfected cultures incubated with host cell adsorption. Multiple monoclonal antidia or with media containing mono-bodies or polyclonal antibodies to GP 90 may be bodies to the nucleocapsid protein needed to clarify the potential role of this protein VP 37 (L2) progressed such that by in cell attachment. That one of the anti-GP 90
Ltire cell sheet was infected and giant antibodies was capable of neutralizing virus in re noted by light microscopy and the presence of complement suggests that neu-, (Fig. 4A and B) . Similarly, incuba-tralization is mediated by viral membrane lysis ted cells with anti-GP 90 antibodies and that antibodies to GP 90 might be important did not inhibit the progression of in immunity to infection. Although able to neu- tralize RSV in the presence of complement, this anti-GP 90 antibody was unable to prevent the spread of infection by cell-cell fusion.
Fernie and Gerin, by analysis of iodinated purified virus under reducing and nonreducing conditions, demonstrated that VP 70 is composed of a 20K and a 50K protein bound by disulfide bonds (9) . Because of the structural similarity to the fusion proteins of other enveloped viruses, they suggested that VP 70 might be the fusion protein of RSV. In contrast to the anti-GP 90 antibodies, our anti-VP 70 antibody neutralized virus in the absence of complement and in addition prevented fusion of RSV-infected cells, thus identifying VP 70 as the fusion protein.
The fusion protein may be involved in the cell penetration step of some enveloped viruses by fusing the viral envelope to the host cell membrane, resulting in delivery of the ribonucleoprotein into the cell cytoplasm (3). Neutralization of RSV by anti-VP 70 antibody might be mediated by inhibition of virus-cell fusion. The anti-VP 70 monoclonal antibody described by Cote et al. differs from ours in that it was able to neutralize virus but did not inhibit cell-cell fusion (5) . This suggests that either the fusion protein facilitates cell adsorption or that neutralization of virus occurs by a mechanism other than inhibition of cell attachment. It is also possible that virus-cell fusion and cell-cell fusion may be mediated by different regions of the fusion protein.
Reinfection with RSV in the presence of circulating neutralizing antibodies is common in both infants and adults. However, the protein specificity of these neutralizing antibodies has not been fully explored. Because may not be as effective in preventing infection as neutralizing antibody that is directed to the fusion protein and can also limit cell-cell spread of virus.
